2-Mercaptoethanol/DMSO Workflow Enables Highly Reproducible Quantitative Proteomics
Journal of Proteome Research · 2026
DOI: 10.1021/acs.jproteome.6c00010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, 2026. Verfasst von Arisa Suto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, School of Science, Kitasato University, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa252-0373, Japan. Hauptthemen laut MEDLINE: Mercaptoethanol, Proteomics, Dimethyl Sulfoxide, Proteome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Kitasato University.
Abstract (Originalsprache)
Proteomics provides a systematic and high-throughput approach to comprehensively characterize protein networks, enabling insights into cellular functions and disease mechanisms. Carbamidomethylation using iodoacetamide (IAA), a common method for cysteine alkylation, is known to cause nonspecific modifications that increase spectral complexity in mass spectrometry and reduce quantitative accuracy. Here, we established a reproducibility-focused 2-mercaptoethanol (2-ME)/dimethyl sulfoxide (DMSO) workflow and systematically evaluated its quantitative performance at the proteome-wide level. Mouse liver proteomes were processed using either 2-ME/DMSO or conventional IAA treatment, followed by liquid chromatography-tandem mass spectrometry (LC–MS/MS) analysis. The optimized 2-ME treatment increased the number of cysteine-modified peptides by 1.6- to 1.9-fold. Although total protein identifications were comparable, 77% of proteins exhibited improved sequence coverage with the optimized 2-ME treatment. Quantitative reproducibility was also enhanced, with the peptide quantified CV ≤ 20% increasing from 61.4% with IAA treatment to 86.1% with 2-ME treatment, and protein quantified CV ≤ 20% increasing from 80.6% with IAA treatment to 93.5% with 2-ME treatment. Application of this new workflow to ovarian clear cell carcinoma reliably detected cisplatin-induced alterations. The 2-ME/DMSO workflow offers a simple and highly reproducible proteomics strategy for accurate quantitative proteomics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physics, School of Science, Kitasato University, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa252-0373, Japan.
- Department of Pathology, School of Allied Health Science, Kitasato University, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa252-0373, Japan.
- Department of Biochemistry, School of Medicine, Kitasato University, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa252-0373, Japan.
- Center for Disease Proteomics, School of Science, Kitasato University, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa252-0373, Japan.
ORCID-Profile: Takashi Matsui
Förderung
- Japan Society for the Promotion of Science
- Kitasato University
Zitieren
APA
Suto, A., Ishikawa, Y., Matsumoto, T., Itakura, M., Kodera, Y., & Matsui, T. (2026). 2-Mercaptoethanol/DMSO Workflow Enables Highly Reproducible Quantitative Proteomics. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.6c00010
Vancouver
Suto A, Ishikawa Y, Matsumoto T, Itakura M, Kodera Y, Matsui T. 2-Mercaptoethanol/DMSO Workflow Enables Highly Reproducible Quantitative Proteomics. Journal of Proteome Research. 2026. doi:10.1021/acs.jproteome.6c00010
BibTeX
@article{Suto2026,
author = {Suto, Arisa and Ishikawa, Yoshihiro and Matsumoto, Toshihide and Itakura, Makoto and Kodera, Yoshio and Matsui, Takashi},
title = {2-Mercaptoethanol/DMSO Workflow Enables Highly Reproducible Quantitative Proteomics},
journal = {Journal of Proteome Research},
year = {2026},
doi = {10.1021/acs.jproteome.6c00010}
}
EUVIMED